PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer
Clinical trial NCT02910882 · TERMINATED
Trial details
- NCT number
- NCT02910882
- Sponsor
- Scripps Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-03
- Primary completion
- 2018-08-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.